InSights Videos

Contract Manufacturing in the Pharmaceutical Industry: Recipharm

Contract Manufacturing in the Pharmaceutical Industry: Recipharm

In this exclusive interview, Fintan Walton, CEO of PharmaVentures, speaks with Marc Funk, the new CEO of Recipharm. Recipharm is a leading Swedish CDMO, founded in 1995, which has expanded to over 30 sites across 10 countries which are mainly in Europe, but also in...

Contract Manufacturing in the Pharmaceutical Industry: Recipharm

Doing deals in the healthcare sector during the Covid-19 pandemic.

The Chief Executive of PharmaVentures, a leading global corporate advisory firm in healthcare licensing, M&A and fundraising discusses how the current pandemic of 2020 will define the winners and losers in biopharmaceuticals. https://youtu.be/o81Th7McuHA

Contract Manufacturing in the Pharmaceutical Industry: Recipharm

Why you should make South Korea a deal making target

Over the past couple of years, we have seen huge growth in the pharma and biotech industries in Asia, and especially in Korea. Historically, the Korean pharmaceutical industry was built on manufacturing and generics capabilities, however, in the past few decades many...

Featured Videos

Please see PharmaVentures Insights YouTube channel for more videos

Blog Articles

Biotech Bounces Back

On the 31st July of this year the Financial Times front page headline to its Companies and Markets...

Our Termsheet

White Papers

Deal Making in the Year of Covid-19

In the Spring of 2020, during the early days of the COVID-19 pandemic when there were real fears of a global downturn, PharmaVentures predicted that despite the forthcoming challenges, licensing and partnering would remain steady during 2020. With the year behind us,...

Our News